Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Olopatadine | hsa00030 | Pentose phosphate pathway | 5.91E-06 | 4 | P60891, P51854, P04075, P37837 | PRPS1, TKTL1, ALDOA, TALDO1 | More | | Olopatadine | hsa00071 | Fatty acid degradation | 1.72E-02 | 4 | P11310, O75521, P11766, P33121 | ACADM, ECI2, ADH5, ACSL1 | More | | Olopatadine | hsa00190 | Oxidative phosphorylation | 5.12E-04 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Olopatadine | hsa00220 | Arginine biosynthesis | 4.33E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Olopatadine | hsa00430 | Taurine and hypotaurine metabolism | 4.49E-02 | 1 | Q14032 | BAAT | More | | Olopatadine | hsa00500 | Starch and sucrose metabolism | 4.66E-02 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Olopatadine | hsa00512 | Mucin type O-glycan biosynthesis | 1.59E-03 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Olopatadine | hsa00514 | Other types of O-glycan biosynthesis | 3.37E-02 | 2 | P15907, Q8N4A0 | ST6GAL1, GALNT4 | More | | Olopatadine | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Olopatadine | hsa00564 | Glycerophospholipid metabolism | 3.93E-02 | 3 | P49619, O14494, Q3LIE5 | DGKG, PLPP1, ADPRM | More | | Olopatadine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 4.29E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Olopatadine | hsa00730 | Thiamine metabolism | 1.15E-03 | 2 | Q9Y6K8, P24666 | AK5, ACP1 | More | | Olopatadine | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Olopatadine | hsa00760 | Nicotinate and nicotinamide metabolism | 2.11E-02 | 2 | P43490, Q13423 | PBEF1, NNT | More | | Olopatadine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Olopatadine | hsa00860 | Porphyrin and chlorophyll metabolism | 1.69E-02 | 2 | P36551, P30043 | CPOX, BLVRB | More | | Olopatadine | hsa00910 | Nitrogen metabolism | 4.33E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Olopatadine | hsa00970 | Aminoacyl-tRNA biosynthesis | 8.60E-05 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Olopatadine | hsa01200 | Carbon metabolism | 4.76E-03 | 7 | P51854, P04406, P37837, O14521, Q9P2R7, P60891, Q02252 | TKTL1, GAPDH, TALDO1, SDHD, SUCLA2, PRPS1, ALDH6A1 | More | | Olopatadine | hsa01230 | Biosynthesis of amino acids | 2.22E-03 | 4 | P51854, P60891, Q99707, P37837 | TKTL1, PRPS1, MTR, TALDO1 | More | | Olopatadine | hsa01240 | Biosynthesis of cofactors | 2.52E-02 | 2 | Q9BQB6, P14550 | VKORC1, AKR1A1 | More | | Olopatadine | hsa02010 | ABC transporters | 1.24E-03 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | | Olopatadine | hsa03008 | Ribosome biogenesis in eukaryotes | 1.88E-02 | 3 | O14980, O60832, Q9BVP2 | XPO1, DKC1, GNL3 | More | | Olopatadine | hsa03010 | Ribosome | 5.87E-03 | 12 | P62753, P39019, P42677, P62906, P62917, Q07020, P61513, Q02878, P63173, P36578, P05386, P23396 | RPS6, RPS19, RPS27, RPL10A, RPL8, RPL18, RPL37A, RPL6, RPL38, RPL4, RPLP1, RPS3 | More | | Olopatadine | hsa03013 | RNA transport | 1.54E-07 | 15 | O14980, P52298, Q09161, O14893, P61326, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, P23588, Q9Y6A5, Q06787, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, EIF4B, TACC3, FMR1, FXR1 | More | | Olopatadine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | | Olopatadine | hsa03040 | Spliceosome | 7.18E-08 | 20 | Q14562, O43143, O60508, O14776, P08579, P26368, O75940, P09651, O75494, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O95777, O43447, O43395, O75643 | DHX8, DHX15, CDC40, TCERG1, SNRPB2, U2AF2, SMNDC1, HNRNPA1, FUSIP1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, LSM8, PPIH, PRPF3, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P06702 | S100A9 | Protein S100-A9 | O14776 | TCERG1 | Transcription elongation regulator 1 | -0.791 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | P06702 | S100A9 | Protein S100-A9 | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | -0.945 | P06702 | S100A9 | Protein S100-A9 | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | -0.762 | P06702 | S100A9 | Protein S100-A9 | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | -0.856 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P06702 | S100A9 | Protein S100-A9 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.783 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P06702 | S100A9 | Protein S100-A9 | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | -0.796 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P06702 | S100A9 | Protein S100-A9 | O43395 | PRPF3 | U4/U6 small nuclear ribonucleoprotein Prp3 | -0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Olopatadine | hsa03410 | Base excision repair | 2.52E-02 | 2 | P49005, P29372 | POLD2, MPG | More | | Olopatadine | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Olopatadine | hsa04015 | Rap1 signaling pathway | 1.79E-02 | 8 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, P42338, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, PIK3CB, PLCG1 | More | | Olopatadine | hsa04024 | cAMP signaling pathway | 4.38E-02 | 4 | P42338, P0DP23, Q13370, Q13009 | PIK3CB, CALM1, PDE3B, TIAM1 | More | | Olopatadine | hsa04060 | Cytokine-cytokine receptor interaction | 4.07E-03 | 14 | P32927, P27930, P01584, P61073, P25024, P25025, Q9UBD3, P47992, P20333, P01375, P09341, Q99731, P18510, Q93038 | CSF2RB, IL1R2, IL1B, CXCR4, CXCR1, CXCR2, XCL2, XCL1, TNFRSF1B, TNF, CXCL1, CCL19, IL1RN, TNFRSF25 | More | | Olopatadine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 5.42E-04 | 11 | Q99731, P09341, P19875, P25024, P25025, P61073, P47992, Q9UBD3, P14784, P20333, P01375 | CCL19, CXCL1, CXCL2, CXCR1, CXCR2, CXCR4, XCL1, XCL2, IL2RB, TNFRSF1B, TNF | More | | Olopatadine | hsa04062 | Chemokine signaling pathway | 7.92E-05 | 15 | P25024, P25025, P09341, P19875, P09769, P07948, P42338, P19174, P63218, P50151, P43250, Q7LDG7, Q13009, P49841, Q8WYR1 | CXCR1, CXCR2, CXCL1, CXCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, RASGRP2, TIAM1, GSK3B, PIK3R5 | More | | Olopatadine | hsa04064 | NF-kappa B signaling pathway | 1.09E-03 | 14 | O00463, P14778, P01584, P01375, P19174, Q04759, Q16548, P06239, P63279, P24522, P09341, P19875, Q99731, Q06643 | TRAF5, IL1R1, IL1B, TNF, PLCG1, PRKCQ, BCL2A1, LCK, UBE2I, GADD45A, CXCL1, CXCL2, CCL19, LTB | More | | Olopatadine | hsa04070 | Phosphatidylinositol signaling system | 4.86E-02 | 3 | P0DP23, P42338, P27987 | CALM1, PIK3CB, ITPKB | More | | Olopatadine | hsa04071 | Sphingolipid signaling pathway | 2.37E-03 | 8 | P21453, Q9H228, P01375, Q13362, Q16537, Q9BX95, Q16539, P10415 | S1PR1, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, MAPK14, BCL2 | More | | Olopatadine | hsa04072 | Phospholipase D signaling pathway | 4.48E-02 | 5 | P42338, P43657, P25024, P25025, P19174 | PIK3CB, P2RY5, CXCR1, CXCR2, PLCG1 | More | | Olopatadine | hsa04080 | Neuroactive ligand-receptor interaction | 8.52E-04 | 9 | P28472, P21453, Q9H228, P43657, Q01726, P21730, P14416, P07550, P35318 | GABRB3, S1PR1, EDG8, P2RY5, MC1R, C5AR1, DRD2, ADRB2, ADM | More | | Olopatadine | hsa04114 | Oocyte meiosis | 2.67E-02 | 7 | Q9UJX2, Q14643, P22694, Q16539, Q14683, Q13362, Q16537 | CDC23, ITPR1, PRKACB, MAPK14, SMC1A, PPP2R5C, PPP2R5E | More | | Olopatadine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Olopatadine | hsa04136 | Autophagy - other | 5.92E-03 | 2 | O94817, Q9H1Y0 | ATG12, ATG5 | More | | Olopatadine | hsa04145 | Phagosome | 3.11E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa04146 | Peroxisome | 7.06E-03 | 2 | Q14032, P00441 | BAAT, SOD1 | More | | Olopatadine | hsa04151 | PI3K-Akt signaling pathway | 3.70E-02 | 12 | P42338, P43657, P20827, P49767, P08238, Q8WYR1, P63218, P50151, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, EFNA1, VEGFC, HSP90AB1, PIK3R5, GNG5, GNG10, CHAD, LAMB3, IL2RB, CCND3 | More | | Olopatadine | hsa04213 | Longevity regulating pathway - multiple species | 4.41E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Olopatadine | hsa04217 | Necroptosis | 2.24E-04 | 12 | P01375, P01568, P48023, Q13489, P42224, Q14765, P08238, Q6FI13, Q99878, Q93077, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, STAT1, STAT4, HSP90AB1, H2AC18; H2AC19, H2AC14, HIST1H2AC, CHMP2A, PPID | More | | Olopatadine | hsa04218 | Cellular senescence | 1.60E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.95E-02 | 4 | P07550, P22694, P18848, Q13362 | ADRB2, PRKACB, ATF4, PPP2R5C | More | | Olopatadine | hsa04360 | Axon guidance | 2.47E-03 | 7 | P16333, P20827, O95631, P42338, P07332, P23528, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1 | More | | Olopatadine | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Olopatadine | hsa04390 | Hippo signaling pathway | 1.52E-02 | 4 | P63261, Q13485, O15105, O43623 | ACTG1, SMAD4, SMAD7, SNAI2 | More | | Olopatadine | hsa04514 | Cell adhesion molecules | 2.20E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa04520 | Adherens junction | 3.44E-02 | 3 | Q13485, O43623, P63261 | SMAD4, SNAI2, ACTG1 | More | | Olopatadine | hsa04610 | Complement and coagulation cascades | 2.78E-03 | 1 | P0C0L4 | C4A | More | | Olopatadine | hsa04612 | Antigen processing and presentation | 1.07E-06 | 10 | P04233, Q14953, P26715, P26717, Q13241, P01732, P01889, P10321, Q06323, P01375 | CD74, KIR2DS5, KLRC1, KLRC2, KLRD1, CD8A, HLA-B, HLA-C, PSME1, TNF | More | | Olopatadine | hsa04613 | Neutrophil extracellular trap formation | 3.76E-04 | 10 | P11215, Q13547, P04908, Q93077, P58876, Q16778, O60814, P68431, O43315, Q16539 | ITGAM, HDAC1, H2AC4; H2AC8, HIST1H2AC, H2BC5, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | | Olopatadine | hsa04623 | Cytosolic DNA-sensing pathway | 3.15E-02 | 2 | P01568, P25963 | IFNA21, NFKBIA | More | | Olopatadine | hsa04640 | Hematopoietic cell lineage | 1.37E-02 | 7 | P14778, P27930, P11215, P25063, P07766, P01732, P09564 | IL1R1, IL1R2, ITGAM, CD24, CD3E, CD8A, CD7 | More | | Olopatadine | hsa04650 | Natural killer cell mediated cytotoxicity | 1.05E-08 | 16 | P19174, P01375, P06239, O60880, P20963, Q29983, P10321, P01889, P42338, Q13241, P26718, O14931, O75015, P26717, Q14953, P26715 | PLCG1, TNF, LCK, SH2D1A, CD247, MICA, HLA-C, HLA-B, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | | Olopatadine | hsa04657 | IL-17 signaling pathway | 2.41E-02 | 4 | P19875, P14780, P80188, P01375 | CXCL2, MMP9, LCN2, TNF | More | | Olopatadine | hsa04658 | Th1 and Th2 cell differentiation | 7.59E-06 | 12 | Q04759, P07766, P20963, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P46531, Q9UM47, Q13761 | PRKCQ, CD3E, CD247, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, NOTCH1, NOTCH3, RUNX3 | More | | Olopatadine | hsa04659 | Th17 cell differentiation | 1.32E-05 | 13 | Q04759, P19174, P06239, P42224, P14784, P14778, P40189, Q9UL17, P84022, Q13485, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, STAT1, IL2RB, IL1R1, IL6ST, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Olopatadine | hsa04660 | T cell receptor signaling pathway | 2.44E-04 | 12 | P01375, Q04759, P42338, O95267, Q08881, P19174, Q9NQU5, P07766, P20963, P01732, Q13191, P06239 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, PAK6, CD3E, CD247, CD8A, CBLB, LCK | More | | Olopatadine | hsa04662 | B cell receptor signaling pathway | 1.33E-03 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Olopatadine | hsa04664 | Fc epsilon RI signaling pathway | 2.66E-03 | 5 | Q16539, P42338, P07948, P19174, P09917 | MAPK14, PIK3CB, LYN, PLCG1, ALOX5 | More | | Olopatadine | hsa04666 | Fc gamma R-mediated phagocytosis | 3.08E-02 | 3 | P42338, P23528, P14598 | PIK3CB, CFL1, NCF1 | More | | Olopatadine | hsa04668 | TNF signaling pathway | 3.38E-03 | 9 | P01375, O00463, P18848, P09341, P19875, P01584, P20749, P14780, P20333 | TNF, TRAF5, ATF4, CXCL1, CXCL2, IL1B, BCL3, MMP9, TNFRSF1B | More | | Olopatadine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | | Olopatadine | hsa04721 | Synaptic vesicle cycle | 3.15E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Olopatadine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Olopatadine | hsa04724 | Glutamatergic synapse | 1.11E-02 | 4 | P43003, P63218, P50151, P15104 | SLC1A3, GNG5, GNG10, GLUL | More | | Olopatadine | hsa04728 | Dopaminergic synapse | 2.96E-02 | 5 | P14416, P63218, P50151, P49841, Q16539 | DRD2, GNG5, GNG10, GSK3B, MAPK14 | More | | Olopatadine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | | Olopatadine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | | Olopatadine | hsa04750 | Inflammatory mediator regulation of TRP channels | 7.24E-03 | 5 | P14778, P19174, P42338, P24723, Q04759 | IL1R1, PLCG1, PIK3CB, PRKCH, PRKCQ | More | | Olopatadine | hsa04913 | Ovarian steroidogenesis | 2.54E-02 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | | Olopatadine | hsa04914 | Progesterone-mediated oocyte maturation | 3.92E-02 | 3 | P42338, Q13370, P08238 | PIK3CB, PDE3B, HSP90AB1 | More | | Olopatadine | hsa04923 | Regulation of lipolysis in adipocytes | 2.24E-02 | 3 | P07550, P42338, Q9Y4H2 | ADRB2, PIK3CB, IRS2 | More | | Olopatadine | hsa04924 | Renin secretion | 2.98E-03 | 4 | P22694, P07550, Q13370, P0DP23 | PRKACB, ADRB2, PDE3B, CALM1 | More | | Olopatadine | hsa04926 | Relaxin signaling pathway | 2.41E-02 | 4 | P18848, P22694, P14780, P30679 | ATF4, PRKACB, MMP9, GNA15 | More | | Olopatadine | hsa04927 | Cortisol synthesis and secretion | 2.54E-02 | 2 | P18848, P22694 | ATF4, PRKACB | More | | Olopatadine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | | Olopatadine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Olopatadine | hsa04940 | Type I diabetes mellitus | 5.99E-04 | 4 | P48023, P01889, P10321, P01375 | FASLG, HLA-B, HLA-C, TNF | More | | Olopatadine | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Olopatadine | hsa04964 | Proximal tubule bicarbonate reclamation | 4.33E-02 | 2 | P22748, P49448 | CA4, GLUD2 | More | | Olopatadine | hsa04970 | Salivary secretion | 1.91E-02 | 3 | P07550, P22694, P49913 | ADRB2, PRKACB, CAMP | More | | Olopatadine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Olopatadine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | | Olopatadine | hsa05014 | Amyotrophic lateral sclerosis | 3.44E-02 | 13 | P01375, P10415, Q16539, Q16718, O14521, Q9NZJ5, Q13561, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, BCL2, MAPK14, NDUFA5, SDHD, EIF2AK3, DCTN2, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | | Olopatadine | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | | Olopatadine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | | Olopatadine | hsa05031 | Amphetamine addiction | 4.32E-02 | 3 | P22694, P18848, Q13547 | PRKACB, ATF4, HDAC1 | More | | Olopatadine | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Olopatadine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 6.67E-05 | 7 | Q16539, P09341, P19875, P19174, P25024, P25025, P07948 | MAPK14, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Olopatadine | hsa05133 | Pertussis | 4.94E-02 | 1 | P0C0L4 | C4A | More | | Olopatadine | hsa05134 | Legionellosis | 1.29E-02 | 4 | P11215, P11142, P09341, P19875 | ITGAM, HSPA8, CXCL1, CXCL2 | More | | Olopatadine | hsa05140 | Leishmaniasis | 1.56E-02 | 5 | P14598, P42224, P25963, P29350, Q15080 | NCF1, STAT1, NFKBIA, PTPN6, NCF4 | More | | Olopatadine | hsa05143 | African trypanosomiasis | 1.78E-03 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Olopatadine | hsa05144 | Malaria | 1.50E-03 | 5 | P60033, P01375, P35443, P01584, P26718 | CD81, TNF, THBS4, IL1B, KLRK1 | More | | Olopatadine | hsa05146 | Amoebiasis | 5.09E-06 | 13 | P01584, P09341, P19875, P14778, P27930, P01375, P42338, P11215, P05089, P30679, P22694, P12814, P08311 | IL1B, CXCL1, CXCL2, IL1R1, IL1R2, TNF, PIK3CB, ITGAM, ARG1, GNA15, PRKACB, ACTN1, CTSG | More | | Olopatadine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Olopatadine | hsa05163 | Human cytomegalovirus infection | 1.60E-02 | 7 | P63218, P50151, Q14344, P49841, P14778, P25025, Q16539 | GNG5, GNG10, GNA13, GSK3B, IL1R1, CXCR2, MAPK14 | More | | Olopatadine | hsa05165 | Human papillomavirus infection | 5.90E-03 | 3 | P01889, P10321, O14745 | HLA-B, HLA-C, SLC9A3R1 | More | | Olopatadine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.22E-03 | 3 | P01889, P10321, Q29983 | HLA-B, HLA-C, MICA | More | | Olopatadine | hsa05168 | Herpes simplex virus 1 infection | 6.29E-06 | 18 | P25963, P01568, Q05823, P42224, Q07955, Q01130, Q13243, P04233, Q13489, P01889, P10321, P42338, Q13398, Q9HCX3, Q03923, P52738, O75820, Q9UDV6 | NFKBIA, IFNA21, RNASEL, STAT1, SFRS1, SFRS2, SFRS5, CD74, BIRC3, HLA-B, HLA-C, PIK3CB, ZNF211, ZNF304, ZNF85, ZNF140, ZNF189, ZNF212 | More | | Olopatadine | hsa05169 | Epstein-Barr virus infection | 2.87E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa05170 | Human immunodeficiency virus 1 infection | 2.87E-02 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa05171 | Coronavirus disease - COVID-19 | 2.56E-02 | 15 | P01375, P01584, P23396, P62753, P39019, P42677, P62906, P36578, Q02878, P62917, Q07020, P61513, P63173, P05386, P21730 | TNF, IL1B, RPS3, RPS6, RPS19, RPS27, RPL10A, RPL4, RPL6, RPL8, RPL18, RPL37A, RPL38, RPLP1, C5AR1 | More | | Olopatadine | hsa05200 | Pathways in cancer | 1.31E-03 | 21 | Q13751, P42338, P08238, P42224, P19174, P43246, P84022, Q13485, Q13547, P14923, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P0DP23, P14784, P40189 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, CALM1, IL2RB, IL6ST | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 |
| Olopatadine | hsa05202 | Transcriptional misregulation in cancer | 4.61E-03 | 12 | P01106, P27930, P11215, P35226, O60583, P04141, P59665, P59666, P42773, Q13547, P12980, O75293 | MYC, IL1R2, ITGAM, BMI1, CCNT2, CSF2, DEFA1; DEFA1B, DEFA3, CDKN2C, HDAC1, LYL1, GADD45B | More | | Olopatadine | hsa05203 | Viral carcinogenesis | 2.65E-04 | 6 | Q13547, P01889, P10321, P58876, Q16778, O60814 | HDAC1, HLA-B, HLA-C, H2BC5, HIST2H2BE, H2BC12 | More | | Olopatadine | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | | Olopatadine | hsa05206 | MicroRNAs in cancer | 3.11E-02 | 6 | P01106, P26358, Q9UM47, P35226, Q96EB6, P19174 | MYC, DNMT1, NOTCH3, BMI1, SIRT1, PLCG1 | More | | Olopatadine | hsa05212 | Pancreatic cancer | 2.14E-03 | 5 | P42338, P42224, P84022, Q13485, O75293 | PIK3CB, STAT1, SMAD3, SMAD4, GADD45B | More | | Olopatadine | hsa05214 | Glioma | 1.72E-02 | 3 | P0DP23, P42338, O75293 | CALM1, PIK3CB, GADD45B | More | | Olopatadine | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Olopatadine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Olopatadine | hsa05320 | Autoimmune thyroid disease | 3.49E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa05321 | Inflammatory bowel disease | 2.06E-03 | 5 | P01375, Q14765, Q9UL17, P23771, P01584 | TNF, STAT4, TBX21, GATA3, IL1B | More | | Olopatadine | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | | Olopatadine | hsa05330 | Allograft rejection | 5.99E-04 | 4 | P01889, P10321, P48023, P01375 | HLA-B, HLA-C, FASLG, TNF | More | | Olopatadine | hsa05332 | Graft-versus-host disease | 3.48E-05 | 6 | P48023, P01889, P10321, P01375, P26715, Q13241 | FASLG, HLA-B, HLA-C, TNF, KLRC1, KLRD1 | More | | Olopatadine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.29E-02 | 4 | P23229, P16144, P60709, P35609 | ITGA6, ITGB4, ACTB, ACTN2 | More | | Olopatadine | hsa05415 | Diabetic cardiomyopathy | 4.54E-04 | 8 | P17252, P14598, Q15080, Q16718, O14521, Q16539, P49841, P04406 | PRKCA, NCF1, NCF4, NDUFA5, SDHD, MAPK14, GSK3B, GAPDH | More | | Olopatadine | hsa05416 | Viral myocarditis | 5.53E-03 | 2 | P01889, P10321 | HLA-B, HLA-C | More | | Olopatadine | hsa05418 | Fluid shear stress and atherosclerosis | 3.73E-02 | 4 | P42338, P14598, P0DP23, P08238 | PIK3CB, NCF1, CALM1, HSP90AB1 | More | | |